The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The effect of the APPRISE mandate on use of erythropoiesis-stimulating agents and transfusion rates in ovarian cancer patients.
Jonathan David Boone
No relevant relationships to disclose
Christy Lynn Walters
No relevant relationships to disclose
Janelle M. Fauci
No relevant relationships to disclose
Jenny M. Whitworth
No relevant relationships to disclose
Kerri S. Bevis
No relevant relationships to disclose
Ronald David Alvarez
No relevant relationships to disclose